Hepatitis B surface antigen (HBsAg) prevalence in Marshall Islands
Marshall Islands: Hepatitis B surface antigen (HBsAg) prevalence was 0.9% in 2024. ▼ Falling
Hepatitis B surface antigen (HBsAg) prevalence in Marshall Islands, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Marshall Islands recorded 0.9% for hepatitis b surface antigen (hbsag) prevalence in 2024. That is the lowest value across all 10 years on record.
Compared with earlier readings it is down 10.0% on the previous year and down 25.0% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Marshall Islands peaked at 1.5% in 2017 and was at its lowest, 0.9%, in 2024.
That places Marshall Islands 36th out of 194 countries with data for 2024, putting it in the top quarter.
Hepatitis B surface antigen (HBsAg) prevalence in Marshall Islands, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 1.2% | — |
| 2016 | 1.4% | +16.7% |
| 2017 | 1.5% | +7.1% |
| 2018 | 1.5% | +0.0% |
| 2019 | 1.2% | -20.0% |
| 2020 | 1.2% | +0.0% |
| 2021 | 1.1% | -8.3% |
| 2022 | 1.0% | -9.1% |
| 2023 | 1.0% | +0.0% |
| 2024 | 0.9% | -10.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.4% | 1.2% | 1.5% | 5 |
| 2020s | 1.0% | 0.9% | 1.2% | 5 |
Countries ranked near Marshall Islands
- 36 Viet Nam 0.9% compare
- 36 Kiribati 0.9% compare
- 39 Sao Tome and Principe 0.8% compare
- 39 Seychelles 0.8% compare
- 39 Mauritius 0.8% compare
- 39 Philippines 0.8% compare
More health data for Marshall Islands
- Heat deaths vs projected death rates, annual growth rate 3.09 % change on previous year (2090)
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates 1,179 (2090)
- Un projection of annual infant deaths 2 (2100)
- Age population, age 07, female, interpolated 401 (2025)
- Age population, age 09, male, interpolated 427 (2025)
- Age population, age 09, female, interpolated 412 (2025)
- Age population, age 08, male, interpolated 423 (2025)
- Age population, age 08, female, interpolated 408 (2025)
- Age population, age 07, male, interpolated 419 (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Marshall Islands?
- Hepatitis b surface antigen (hbsag) prevalence in Marshall Islands was 0.9% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Marshall Islands?
- The highest recorded value was 1.5% in 2017.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Marshall Islands?
- The lowest recorded value was 0.9% in 2024.
- How does Marshall Islands rank for hepatitis b surface antigen (hbsag) prevalence?
- Marshall Islands ranks 36th out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Marshall Islands?
- Over the last ten years it is down 25.0%. The long-run trend across the full record is falling.
- Where does this Marshall Islands data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).